Media coverage of HCCI’s original research

For general media inquiries or to propose collaborative projects, please contact us

CNBC: Walmart unveils low-price insulin as more patients with diabetes struggle to pay for drug

HCCI's research on the price of insulin was featured in CNBC. 

From the article: "As the number of people with diabetes climbs, the cost of the 100-year-old drug has soared rather than fallen and drawn scrutiny from lawmakers. The annual cost of insulin for people with Type 1 diabetes in the U.S. nearly doubled from $2,900 in 2012 to $5,700 in 2016, according to the most recent data available from the Health Care Cost Institute."


Walmart unveils low-price analog insulin amid rising diabetes drug costs

Walmart said Tuesday it will offer a less expensive version of insulin that could better fit into the budgets of millions of Americans who don't have health insurance or struggle to pay for the lifesaving diabetes drug.

By accepting you will be accessing a service provided by a third-party external to